The content on this site is intended for healthcare professionals only
Cancer patient symptom and physical function reporting by caregivers used as pre...
Dr Elad Neeman - Kaiser Permanente San Francisco Medical Center, San Francisco, ...
21 Jun 2022
War in Ukraine: Global cancer aid to support refugees
Dr Horia Vulpe , Dr Ruslan Baltaga
21 Jun 2022
ASCO and WHO to collaborate on quality indicators for cancer facilities
Dr André Ilbawi - WHO Headquarters, Geneva, Switzerland
14 Jun 2022
Spotlight on global cancer control at ASCO 2022
Prof Eduardo Cazap - Editor-in-Chief, ecancer and SLACOM
10 Jun 2022
UICC announces global coalition to increase access to essential cancer medicines...
Dr Cary Adams - Chief Executive Officer, Union for International Cancer Control
9 Jun 2022
Pancreatic neuroendocrine tumours: Capecitabine plus temozolomide gives longer P...
Dr Pamela Kunz - Yale Cancer Center, New Haven, USA
6 Jun 2022
Outcomes of clinico-radiologically advanced cancer (cT4b) of buccal mucosa: A re...
Dr Prateek Jain - Tata Medical Center, Kolkata, India
25 May 2022
Novel bispecific checkpoint inhibitor MEDI5752 shows promise for advanced solid ...
Dr Ben Tran - Peter MacCallum Cancer Centre, Melbourne, Australia
14 Apr 2022
PETRA: Next generation PARP1-selective inhibitor AZD5305 in patients with BRCA1/...
Dr Timothy Yap - MD Anderson Cancer Center, Houston, USA
13 Apr 2022
Durvalumab plus chemotherapy significantly improved OS in advanced biliary tract...
Dr Do-Youn Oh - Seoul National University College of Medicine, Seoul, South Kore...
27 Jan 2022
HIMALAYA: Study of tremelimumab and durvalumab as first-line therapy in patients...
Dr Ghassan K. Abou-Alfa - Memorial Sloan Kettering Cancer Center, New York, USA
27 Jan 2022
OncoAlert Colloquium Day 4: GI oncology and EONS
Dr Cathy Eng, Dr Yelena Janjigian, Ms Stacy Hurt, Ms Allison Rosen, Dr Mark Lewi...
19 Jan 2022